Venus Remedies Limited
Venus Remedies Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: VENUSREM and BSE: 526953 (ISIN INE411B01019).
It has a market capitalisation of ₹2,130 crore, a last close of ₹1,593 on 2026-10-19, a one-year return of 252.6%.
Valuation: a price-to-book ratio of 3.21x, a dividend yield of 0.6%.
Profitability: return on equity of 0.0%, return on capital employed of 21.1%, an operating margin of 20.5%.
Growth: sales growth of 11.5% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 41.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 2,130 |
| Last close | ₹1,593 |
| P/B | 3.21x |
| Dividend yield | 0.6% |
| ROE (FY) | 0.0% |
| ROCE (FY) | 21.1% |
| Operating margin (TTM) | 20.5% |
| Sales growth, 3-year CAGR | 11.5% |
| Debt / equity | 0.00x |
| Promoter holding | 41.8% |
| 1-year return | 252.6% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means